Related Experiment Video
Updated: May 18, 2026
12:27
Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
The transjugular intrahepatic portosystemic shunt: an update
Nicholas Fidelman1, Sharon W Kwan, Jeanne M LaBerge
1Department of Radiology, University of California San Francisco, 505 Parnassus Ave, Rm M-361, San Francisco, CA 94143, USA. Nicholas.Fidelman@ucsf.edu
AJR. American Journal of Roentgenology
|September 22, 2012
Summary
Transjugular intrahepatic portosystemic shunt (TIPS) creation is effective for preventing variceal bleeding and managing refractory ascites. Advances like covered stents have significantly improved long-term shunt patency and outcomes.
Area of Science:
- Interventional Radiology
- Hepatology
- Vascular Surgery
Background:
- Portal hypertension is a serious complication of liver disease.
- Variceal bleeding and refractory ascites are common, life-threatening consequences.
- Transjugular intrahepatic portosystemic shunt (TIPS) creation is an established treatment modality.
Purpose of the Study:
- To comprehensively review the indications for TIPS.
- To analyze the outcomes and potential complications associated with TIPS.
- To discuss patient selection criteria and technical aspects of the TIPS procedure.
Main Methods:
- Review of current medical literature and evidence-based guidelines.
- Analysis of clinical outcomes and complication rates from published studies.
- Discussion of technical considerations for performing TIPS procedures.
Main Results:
- TIPS is strongly indicated for secondary prevention of variceal bleeding.
- TIPS demonstrates efficacy in managing refractory ascites.
- Covered stents have markedly enhanced long-term shunt patency.
Conclusions:
- TIPS is a valuable intervention for specific liver conditions.
- Evidence supports TIPS for preventing recurrent variceal bleeding and treating ascites.
- Technological advancements, particularly covered stents, have improved TIPS efficacy and durability.
Related Concept Videos
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:21Hepatic Portal System
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...